Evidence map›Paper›PMID 18688039›Full record

ArticleAmerican journal of respiratory cell and molecular biology2009

RelB is differentially regulated by IkappaB Kinase-alpha in B cells and mouse lung by cigarette smoke.

Se-Ran Yang, Hongwei Yao, Saravanan Rajendrasozhan, Sangwoon Chung, Indika Edirisinghe, Samantha Valvo, George Fromm, Michael J McCabe, Patricia J Sime, Richard P Phipps and 3 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. PGAM5 Modulates Macrophage Polarization, Aggravating Inflammation in COPD via the NF-κB Pathway.International journal of chronic obstructive pulmonary disease · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Whole-Exome Sequencing Implicates theFrontiers in cell and developmental biology · 2021
    Article
  7. Article
  8. Innate Immune Responses and Pulmonary Diseases.Advances in experimental medicine and biology · 2021
    Article
  9. Article
  10. Blockade of RAGE ameliorates elastase-induced emphysema development and progressionFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2017
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Se-Ran YangDepartment of Environmental Medicine, University of Rochester Medical Center, Box 850, 601 Elmwood Ave., Rochester, NY 14642, USA.
Hongwei Yao
Saravanan Rajendrasozhan
Sangwoon Chung
Indika Edirisinghe
Samantha Valvo
George Fromm
Michael J McCabe
Patricia J Sime
Richard P Phipps
Jian-Dong Li
Michael Bulger
Irfan Rahman
Bipar · FRUniversity of Rochester Medical Center · USPediatrics and Genetics · USUniversity of Edinburgh · GB

Funding

VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI B Paige Lawrence · 1985 to 2026
$42.8M
MECHANISMS OF CIGARETTE SMOKE-INDUCED LUNG CELLULAR SENESCENCER01HL085613 · NHLBI · UNIVERSITY OF ROCHESTER · PI RAHMAN, IRFAN · 2007 to 2017
$4.0M
REGULATION OF IMMUNITY BY PROSTAGLANDINSR01DE011390 · NIDCR · UNIVERSITY OF ROCHESTER · PI PHIPPS, RICHARD P. · 1994 to 2009
$2.7M
Role of the Aryl Hydrocarbon Receptor in Lung InflammationR01HL088325 · NHLBI · UNIVERSITY OF ROCHESTER · PI SIME, PATRICIA JANET · 2008 to 2012
$1.9M
NHLBI NIH HHS HL088325NHLBI NIH HHS R01-HL085613NIDCR NIH HHS DE011390NIEHS NIH HHS ES-01247
6 · The paper itself

Abstract

The activation of transcription factor NF-kappaB is controlled by two main pathways: the classical canonical (RelA/p65-p50)- and the alternative noncanonical (RelB/p52)-NF-kappaB pathways. RelB has been shown to play a protective role in RelA/p65-mediated proinflammatory cytokine release in immune-inflammatory lymphoid cells. Increased infiltration of macrophages and lymphoid cells occurs in lungs of patients with chronic obstructive pulmonary disease, leading to abnormal inflammation. We hypothesized that RelB, and its signaling pathway, is differentially regulated in macrophages and B cells and in lung cells, leading to differential regulation of proinflammatory cytokines in response to cigarette smoke (CS). CS exposure increased the levels of RelB and NF-kappaB-inducing kinase associated with recruitment of RelB on promoters of the IL-6 and macrophage inflammatory protein-2 genes in mouse lung. Treatment of macrophage cell line, MonoMac6, with CS extract showed activation of RelB. In contrast, RelB was degraded by a proteasome-dependent mechanism in B lymphocytes (human Ramos, mouse WEHI-231, and primary mouse spleen B cells), suggesting that RelB is differentially regulated in lung inflammatory and lymphoid cells in response to CS exposure. Transient transfection of dominant negative IkappaB-kinase-alpha and double mutants of NF-kappaB-inducing kinase partially attenuated the CS extract-mediated loss of RelB in B cells and normalized the increased RelB level in macrophages. Taken together, these data suggest that RelB is differentially regulated in response to CS exposure in macrophages, B cells, and in lung cells by IkappaB-kinase-alpha-dependent mechanism. Rapid degradation of RelB signals for RelA/p65 activation and loss of its protective ability to suppress the proinflammatory cytokine release in lymphoid B cells.

Indexed as

AnimalsB-LymphocytesCD40 LigandCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DifferentiationCell LineCell ProliferationCell SurvivalGene Expression RegulationHumansI-kappa B KinaseInterleukin-1betaLungLymphotoxin-betaMacrophages, AlveolarCD40 LigandChuk protein, mouseI-kappa B KinaseInterleukin-1betaLtb protein, mouseLymphotoxin-betaRela protein, mouseRELB protein, humanRelb protein, mouseTranscription Factor RelATranscription Factor RelB

Identifiers

PMID18688039
PMCPMC2633139
OpenAlexW2091125000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.